Medical/Pharmaceuticals

ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

MELBOURNE, Australia, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into the Phase III pivotal study ZIRCON (Zirconium in Renal Cancer Oncology, NCT03849118) of its investiga...

2022-07-11 08:26 3364

Kevin Richardson appointed as CEO, Telix Americas

MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce thatKevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical mar...

2022-07-11 08:13 3643

CORDIS NAMES BRYAN LOO PRESIDENT OF ASIA-PACIFIC REGION

Seasoned medical technology leader tapped to maximize momentum in APAC MIAMI LAKES, Fla., July 8, 2022 /PRNewswire/ -- Cordis, a global leader in cardiovascular technologies, today announced thatBryan Loo will assume the role of President of theAsia-Pacific (APAC) region effective July 18, 2022. ...

2022-07-08 22:00 13162

HKUMed and CityU Scientists Discover Non-invasive Stimulation of the Eye for Depression and Dementia

HONG KONG, July 8, 2022 /PRNewswire/ -- A joint research team from Li Ka Shing Faculty of Medicine, TheUniversity of Hong Kong (HKUMed) and City University of Hong Kong (CityU) has discovered that electrical stimulation of the eye surface can alleviate depression-like symptoms and improve cogniti...

2022-07-08 12:30 4421

iGene Laboratory launches Monkeypox PCR test for the South East Asian region.

SINGAPORE, July 8, 2022 /PRNewswire/ -- iGene Laboratory, the molecular diagnostics laboratory subsidiary of INEX Innovate Pte Ltd, announces the launch of its research-use-only (RUO) polymerase chain reaction (PCR) Monkeypox test in response to the recent outbreak of the virus.

2022-07-08 12:25 4034

A new study confirms: EMDR therapy can be done effectively online with remotEMDR

WORCESTER, England, July 8, 2022 /PRNewswire/ -- A first of its kind academic research confirms that conducting online EMDR therapy usingremotEMDR , the world's leading platform for online EMDR therapy, ...

2022-07-08 07:01 3215

Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle

* Exyte named as general contractor (EPCQ contract partner) * Project is part of the German government's program to prepare for future pandemics * Implementation in less than 24 months thanks to ExyCell® modular system * Lighthouse project for the strategic growth segment of Biopharma and L...

2022-07-08 06:58 5746

HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol

* Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX's Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience * Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of bre...

2022-07-08 05:30 3624

Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine

* Insilico and its collaborators scoured massive datasets and found genes relevant to ALS through PandaOmics™, Insilico's proprietary AI-driven target identification engine. * 28 targets were identified from CNS and diMN samples; for 18 targets (64%), suppression moderately or strongly rescue...

2022-07-08 04:00 4077

ASUS and Tan Tock Seng Hospital co-develop an AI-based tool to improve the accuracy and efficiency of diagnosis in blood diseases

Both parties inked an MOU to accelerate integration of AI-powered solutions into clinical care, to supportSingapore's healthcare transformation SINGAPORE, July 7, 2022 /PRNewswire/ -- ASUS and Tan Tock Seng Hospital (TTSH) inked a three-year Memorandum of Understanding (MOU) earlier today to for...

2022-07-07 16:05 4317

Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China

The Company is working closely with its commercial partners to supply the combination therapy to patients in need  Brii Bio progressed the combination therapy from discovery to global Phase 3 data readout  and first regulatory approval by the China NMPA in less than 20 months, validating the Com...

2022-07-07 07:10 5392

SHARE: RESTORING MENTAL HEALTH IN THE NEW NORMAL

SINGAPORE, July 7, 2022 /PRNewswire/ -- TheShareCo announces the launch ofShare, a Singapore-based mental health app that allows students, parents and working adults to seek online therapy in an affordable, accessible and anonymous manner. It is believed to be the fi...

2022-07-07 07:07 3050

Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

HONG KONG, July 7, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that an injunction order (the "Order"...

2022-07-07 04:16 4710

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials SINGAPORE, July 6, 2022 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company,...

2022-07-06 18:17 5666

Vieworks to Highlight Its X-ray Flat Panel Detectors Lineup at ECR 2022

ANYANG, South Korea, July 6, 2022 /PRNewswire/ -- Vieworks, a global digital X-ray imaging solution provider based inSouth Korea, is showcasing its 3rd generation DR detectors and its latest dynamic detectors at ECR 2022 (Expo3 #322) fromJuly 13th to 17th.

2022-07-06 15:00 2598

Farrer Park Hospital Underscores Commitment to Sustainability with Ongoing Green Initiatives

SINGAPORE, July 6, 2022 /PRNewswire/ -- Sustainability efforts were already embedded in Farrer Park Hospital's ("FPH" or "the Hospital") DNA since its early phase of conceptualisation. Since FPH went operational in 2014, the Hospital has attained optimal energy savings of 30 per cent annually....

2022-07-06 14:00 4296

harrison.ai and Sonic Healthcare join forces to launch 'franklin.ai', bringing Artificial Intelligence (AI) to pathology

franklin.ai aims to apply the latest methodologies in artificial intelligence (AI) to putgroundbreaking AI tools into the hands of pathologists. SYDNEY, July 6, 2022 /PRNewswire/ -- harrison.ai , the clinically led healthcare AI platform andSonic

2022-07-06 09:58 10379

Esco Lifesciences Group Strengthens IVF Portfolio by Acquiring Evidence Solution

SINGAPORE, July 6, 2022 /PRNewswire/ -- Esco Lifesciences Group ("Esco", the "Company") announces the full acquisition of Evidence Solution ("Evidence"), a Danish software company offering In Vitro Fertilization (IVF) management technologies and quality management systems ("Evidence witness syste...

2022-07-06 09:00 2535

Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19

-- ASC10 is an oral small molecule drug candidate, which is in-house discovered and developed, and Ascletis retains full global rights for its development and commercialization --This IND filing of ASC10 in the U.S. will accelerate Ascletis' global multi-center clinical studies on ASC10 and bett...

2022-07-06 08:10 5076

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

Added 16,423 New Subscribers in 4QFY22 4QFY22 Revenues Down 1.7% YoY to RMB297.2 Million ($46.9 Million) 4QFY22 Gross Profit Down 0.5% YoY to RMB255.2 Million ($40.3 Million) 4QFY22 Operating Income Down 4.1% YoY to RMB142.1 Million ($22.4 Million) 4QFY22 Non-GAAP Operating Income Down 4.1% YoY ...

2022-07-06 04:16 5278
1 ... 309310311312313314315 ... 381

Week's Top Stories